Health

So far Johnson & Johnson Vaccine approved for US use only; roll out in States by end of March

Published

3 years ago

March 1, 2021

#USA, March 1, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) on February 27 (2021) announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older.

This decision was based on the totality of scientific evidence, including data from the Phase 3 ENSEMBLE study that demonstrated the vaccine was 85 percent effective in preventing severe disease across all regions studied, and showed protection against COVID-19 related hospitalization and death, beginning 28 days after vaccination.

The terms of the EUA allow use of the vaccine while more data are gathered. The Company plans to file for a Biologics License Application (BLA) with the FDA later in 2021.

“This milestone follows a year of incredible work by our dedicated teams and unprecedented collaboration with health leaders around the world – all of whom shared a goal of bringing a single-shot vaccine to the public,” said Alex Gorsky, Chairman and Chief Executive Officer at Johnson & Johnson. “We will do everything we can to help bring this pandemic to an end, in the United States and throughout the world.”

“We believe the Johnson & Johnson single-shot COVID-19 vaccine is a critical tool for fighting this global pandemic, particularly as it shows protection across countries with different variants. A vaccine that protects against COVID-19, especially against the most dire outcomes of hospitalization and death, will help ease the burden on people and the strain on health systems worldwide,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. “We look forward to our continued efforts around the world as we collectively aim to change the trajectory of this global pandemic.”

Johnson & Johnson is committed to making its COVID-19 vaccine available on a not-for-profit basis for emergency pandemic use. The Company has begun shipping its COVID-19 vaccine and expects to deliver enough single-shot vaccines by the end of March to enable the full vaccination of more than 20 million people in the U.S. The Company plans to deliver 100 million single-shot vaccines to the U.S. during the first half of 2021. The U.S. government will manage allocation and distribution of the vaccine in the U.S. This will be prioritized according to the populations identified by the CDC’s Advisory Committee on Immunization Practices (ACIP) guidelines.

Johnson & Johnson also recently announced its submission of a European Conditional Marketing Authorisation Application to the European Medicines Agency as well as its filing for an Emergency Use Listing (EUL) with the World Health Organization for its COVID-19 vaccine candidate. In addition, rolling submissions for the single-dose COVID-19 vaccine candidate have been initiated in several countries worldwide.

The EUA follows a unanimous vote by the U.S. FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) on February 26, 2021.

“We are thankful for the efforts of all those who have volunteered to participate in our clinical trials, our scientists, collaborators, clinical trial sites and investigators. Through the combined commitment of everyone involved, we have been able to discover, develop and manufacture a single-shot COVID-19 vaccine to protect people around the world,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, Johnson & Johnson.

Related Topics:#coronavirus #covidvaccine #johnsonandjohnson #magneticmedianews

Up Next

Newly Elected MPs make inaugural tour of Cheshire Hall Medical Centre to assess the COVID-19 response

Don't Miss

Governor Explains appointment of Non-indigenous Turks and Caicos Islanders to the House

Deandrea Hamilton

Health

Successful Community Kidney Screening Events Hosted by InterHealth Canada – TCI Hospital and Ministry of Health and Human Services in Grand Turk and Salt Cay

Published

4 days ago

May 2, 2024

Shanieka

(Providenciales, Turks and Caicos Islands – Friday, April 19th, 2024): – InterHealth Canada Turks and Caicos Islands Hospital, in partnership with the Ministry of Health and Human Services, is delighted to announce the successful completion of the Community Kidney Screening Events held in Grand Turk and Salt Cay. These events marked a significant milestone in promoting kidney health awareness and early detection.

On April 12, 2024, on Grand Turk (Dillon Hall) and April 13, 2024, on Salt Cay (Ministry of Health Clinic), participants had the opportunity to receive immediate screening results and personalized guidance from dedicated healthcare professionals. The collaborative effort between InterHealth Canada-Turks and Caicos Islands Hospital and the Ministry of Health and Human Services empowered individuals to prioritize their kidney health and take proactive steps towards well-being.

Reflecting on the event’s success, Dr Denise Braithwaite-Tennant, CEO of InterHealth Canada Turks and Caicos Islands Hospital, shared, “We are happy to see the positive impact of the Community Kidney Screening Events in Grand Turk and Salt Cay. By providing accessible screenings and expert guidance by our clinical teams, including our nephrologist and internist, we equip individuals with the knowledge to make informed decisions about their kidney health.”

Similarly, Dr Camelia Clarke, Director of the Health Promotion and Advocacy Unit of the Ministry of Health and Human Services, expressed her satisfaction with the outcomes, stating, “These events have showcased the importance of early detection and preventive care in maintaining optimal kidney health.”

The support of sponsors, including the TCI Boating Club, Air and Sea Agency, The Olympic Group Limited, Flow and Digicel, played a crucial role in the success of the Community Kidney Screening Events.

InterHealth-Canada Turks and Caicos Islands Hospital and the Ministry of Health and Human Services are excited to announce that a series of Kidney Community Screenings with dates for Providenciales, North and Middle Caicos, and South Caicos will be revealed soon, further extending the impact of this important initiative.

The Community Kidney Screening Events in Grand Turk and Salt Cay have set a solid foundation for ongoing efforts to prioritize kidney health and well-being within the community. Together, we are taking proactive steps towards building a healthier future for all.

Health

Provo Water Company Continues Efforts to Address Water Supply Issues

Published

4 days ago

May 2, 2024

Shanieka

PROVIDENCIALES, TCI, APRIL 30, 2024: Provo Water Company (PWC) has made significant progress in addressing recent water supply issues caused by increased water demand on Providenciales, and while ongoing projects aimed at long-term solutions are proceeding as planned, nightly water restrictions will continue through May.

This news comes as an update on the organization’s swift response to the rising water demand, which prompted the initial implementation of nightly restrictions to safeguard daily water reserves. The company is actively pursuing multiple projects, including upgrades to the city water transmission main, the main city water line valves, and the Middle Booster Pump Station,
alongside various other initiatives, to ensure long-term solutions to the supply issues.

Provo Water Company reaffirms its dedication to the residents of Turks and Caicos by continuing with a range of improvement projects aimed at innovative solutions for short and long-term distribution challenges. While diligently advancing these initiatives, the organization has determined that the nightly water restrictions remain necessary to ensure the replenishment of
daily reserves as it strives to keep these projects on track.

These restrictions will be implemented on an as-needed basis to effectively manage water consumption efficiently. If deemed necessary, the restrictions will be in effect from 11:30 p.m. to 5:30 a.m., optimizing conservation efforts during off-peak hours.

In response to the extension, Managing Director Robert Hall expressed apologies to customers and stakeholders in light of the extension. He reiterates his organization’s dedicated efforts to minimize the frequency of water restrictions and their eventual elimination in response to the extension.

In a statement, Hall said, “We will implement these measures only as required throughout the month of May to efficiently regulate water usage. We recognize the impact of these restrictions, and we want to assure you that we are doing our utmost to minimize inconvenience and ensure that your needs are our top priority.”

The transmission main project, which will enhance various aspects of the existing water supply network, ultimately improving water distribution across the island, is currently scheduled to be completed by mid-June 2024.

Hall concluded, “This project is pivotal in strengthening our water distribution infrastructure, improving operational efficiency, and ensuring a reliable water supply for our community. By actively working towards its completion, we remain dedicated to serving our customers with the utmost excellence, reliability, and efficiency.”

Learn more about Provo Water Company’s water efficiency and conservation initiatives by visiting www.provowater.com. Follow on social media for tips and announcements: @ProvoWaterCompany on Facebook and @provowaterco on Instagram. For inquiries, please contact the customer service team at customerservice@provowater.com.

Health

Dengue Getting Worst

Published

1 week ago

April 27, 2024

Shanieka

Rashaed Esson

Staff Writer

#Dengue#Caribbean#CentralandSouthAmerica, April 25, 2024 – New data from the Pan American Organisation(PAHO), indicates that dengue in the region may hit an all time high now over 4 million cases, a 260 percent increase from 2023 with over 1700 deaths registered since mid April. In fact, since April, reports say Brazil has reported the most cases. As a result of the surge in cases, the U.S. Centers for Disease Control and Prevention (CDC), reissued its Level 1 Travel Health Advisory for the Americas on April 18, 2024 and the countries listed include the Turks and Caicos, Guadeloupe and French Guiana, as they have been seeing higher than usual levels of infection.